Tumor enhancement at contrast-enhanced CT and Gd-enhanced MRI for the assessment of treatment response of hepatocellular carcinoma (HCC) after sorafenib

Scopo: To investigate whether arterial enhancement of advanced HCC during pre-treatment and follow-up contrast-enhanced CT (CECT) or Gd-enhanced MRI (Gd-MRI) can be used to predict tumor response to sorafenib. Materiali e metodi: Seventeen patients (12M, 5F; mean age: 69 years) receiving sorafenib for inoperable HCC between 2007 and 2010 were included. Median interval time between pre-treatment and follow-up CECT or Gd-MRI was 160 days. Tumor arterial enhancement was measured at baseline and follow-up: (tumor attenuation/intensity on arterial phase – tumor attenuation/intensity on unenh! anced images)/(tumor attenuation/intensity on unenhanced images) x 100. Response was assessed according …

Eppure,sembrava una neoplasia...Anomala localizzazione laringea di tiroide ectopica

Evoluzione tettonica mesozoica-terziaria della Sicilia centro-settentrionale

From compression to exstension during the Sicily chain building

Biological effects from ultrasounds with pulse inversion and contrast medium on the rabbit liver

ANOMALUS IMPREGNATION OF THE HEPATIC PARENCHYMA AFTER INTRODUCTION OF ECOGRAFIC CONTRAST MEDIUM